Search results for "Urinary system"

showing 10 items of 347 documents

Congenital Pediatric Diseases

2008

Major congenital malformations are diagnosed in 4%–6% of all infants and fetuses (Lynberg and Edmonds 1992). About one third of them are the leading cause for infant mortality or morbidity (Grandjean et al. 1999). Malformations of the internal urogenital system are diagnosed in about 1% of all infants and account for approximately 20% of all congenital malformations, thus being one of the three most frequent birth defects (Table 11.1.1). Therefore a pre- and/or postnatally performed ultrasound screening for malformations of the internal urogenital system should be part of the routine to reduce perinatal mortality and morbidity. The reliability and value of ultrasonographic screening for con…

Pediatricsmedicine.medical_specialtyFetusbusiness.industryGenitourinary systemUltrasound screeningPerinatal mortalitymedicineCongenital malformationsBreech positionbusinessInfant mortalityURINARY TRACT MALFORMATION
researchProduct

Antenatal Ultrasound Diagnosis of Congenital Malformations of the Urinary Tract: Results and Criticism

1986

From October 1979 to June 1983 220 malformations were diagnosed antenatally at our hospital; 55 (25%) were malformations of the urinary tract, 21 of them hydronephroses and 34 of them dysplasias.

Pediatricsmedicine.medical_specialtyHydronephrosesFetal surgerybusiness.industrymedicine.medical_treatmentUrinary systemmedicineCongenital malformationsAntenatal ultrasoundbusiness
researchProduct

PO-0096 Clinical Effectiveness Of Idursulfase In Boys Aged 0–5 Years With Hunter Syndrome: 3-year Data From The Hunter Outcome Survey

2014

Background and aims Symptoms of Hunter syndrome typically become apparent at 2–4 years of age. Previous analyses have demonstrated improvements in certain clinical measures in young patients receiving idursulfase (Shire); however, data on long-term idursulfase use in these patients remain limited. This analysis used data available in the Hunter Outcome Survey (HOS), a global, observational registry sponsored by Shire, to investigate long-term effectiveness of idursulfase in boys with Hunter syndrome aged 0–5 years. Methods As of January 2014, 260/564 males followed prospectively in HOS had received ≥1 idursulfase infusion (excluding those who had received a bone marrow transplant or were en…

Pediatricsmedicine.medical_specialtyIdursulfaseClinical effectivenessbusiness.industryUrinary systemHunter syndromemedicine.diseaseRheumatologyClinical trialInternal medicinePediatrics Perinatology and Child HealthmedicineObservational studybusinessmedicine.drugLiver sizeArchives of Disease in Childhood
researchProduct

Leitlinien international – Diagnose und Management fieberhafter Harnwegsinfektionen im Säuglings- und Kleinkindesalter – AAP-Guidelines 2011

2012

Pediatricsmedicine.medical_specialtybusiness.industryUrologyUrinary systemmedicineEarly childhoodbusinessAktuelle Urologie
researchProduct

Evaluation of a fluorosis prevention educational program: A randomized field trial.

2017

Background A 2-group randomized field trial was conducted to evaluate the impact of a fluorosis educational preventive program in mother´s knowledge and practices, and on the urine fluoride concentration of their preschool children. Material and Methods A group of 139 mother-child pairs participated in the study. Randomly, children were assigned to an intervention group, their mothers were participants of an educational program, or a control group (CG); including 69 and 70 child-mother pairs, respectively, the follow-up period was six months. Mother´s knowledge and practices were evaluated and children´s first urine sample was used to measure fluoride concentration at the beginning of the s…

Pediatricsmedicine.medical_specialtybusiness.product_categoryUrinary systemIntervention groupUrine03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemedicineWater fluoride030212 general & internal medicineGeneral DentistryToothpastebusiness.industryResearch030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Community and Preventive DentistrychemistryUNESCO::CIENCIAS MÉDICASbusinessFluorideEducational programDental fluorosisJournal of clinical and experimental dentistry
researchProduct

Urinaryp-cresol is elevated in young French children with autism spectrum disorder: a replication study

2014

The aromatic compound p-cresol (4-methylphenol) has been found elevated in the urines of Italian autistic children up to 8 years of age. The present study aims at replicating these initial findings in an ethnically distinct sample and at extending them by measuring also the three components of urinary p-cresol, namely p-cresylsulfate, p-cresylglucuronate and free p-cresol. Total urinary p-cresol, p-cresylsulfate and p-cresylglucuronate were significantly elevated in 33 French autism spectrum disorder (ASD) cases compared with 33 sex- and age-matched controls (p < 0.05). This increase was limited to ASD children aged ≤8 years (p < 0.01), and not older (p = 0.17). Urinary levels of p-cresol a…

Pervasive developmental disordersMalePathologyHealth Toxicology and MutagenesisClinical BiochemistryBiochemistryClinical biochemistryCresolsorganic contaminants; neurotoxicity; Gut flora; pervasive developmental disorders; p-cresylsulfateUrinary levelsneurotoxicityChildSettore BIO/12P-cresylsulfateSettore MED/39 - Neuropsichiatria InfantileGut flora neurotoxicity organic contaminants p-cresylsulfate pervasive developmental disordersHealthAutism spectrum disorderChild Preschoolp-cresylsulfateBiomarker (medicine)FemaleFrancemedicine.medical_specialtyChild Development DisordersAdolescentUrinary systemGlucuronatesSulfuric Acid EstersOrganic contaminantsGut flora; Neurotoxicity; Organic contaminants; p-cresylsulfate; Pervasive developmental disorders; Adolescent; Case-Control Studies; Child; Child Development Disorders; Pervasive; Child; Preschool; Cresols; Female; France; Glucuronates; Humans; Male; Sulfuric Acid Esters; Biochemistry; Clinical Biochemistry; Health; Toxicology and MutagenesisInternal medicineparasitic diseasesNeurotoxicitymedicineHumansToxicology and MutagenesisPreschoolSettore BIO/10 - BIOCHIMICAPervasiveGut florabusiness.industryCase-control studypervasive developmental disordersmedicine.diseaseChild Development Disorders PervasiveCase-Control StudiesAutismorganic contaminantsGut flora; Neurotoxicity; Organic contaminants; p-cresylsulfate; Pervasive developmental disorders; Adolescent; Case-Control Studies; Child; Child Development Disorders Pervasive; Child Preschool; Cresols; Female; France; Glucuronates; Humans; Male; Sulfuric Acid Esters; Biochemistry; Clinical Biochemistry; Health Toxicology and MutagenesisbusinessBiomarkers
researchProduct

Feasibility of shotgun urinary proteomics for investigating prematurely born preschoolers (PBP)

2016

Background: Preterms and twins are at higher risk of respiratory morbidity later in life. Advances in proteomic approaches may allow the characterization of biomarkers involved in respiratory diseases (Mauri et al. Imm. Lett. 2014;162:2-10). Gel-free approach quantitatively identify differentially expressed proteins in relation to physiopathological conditions (Mauri&amp;Dehò, Meth Enzymology 2008;447:99-117). This can improve the clinical reliability of the next generation of biomarkers to discriminate multiple phenotypes of childhood respiratory diseases. Aim: To assess the ability of gel-free proteomics for identifying specific protein profiles related to PBP. Methods: Urine samples were…

Proteomicsbusiness.industryUrinary systemShotgunBioinformaticsProteomicsPulmonary function testingchildrenPretermRespiratory morbidityClinical informationPreterm childrenMedicinebusinessClinical phenotypeUrine sample
researchProduct

Toxicidad pulmonar por talidomida

2002

Although the side effects of thalidomide are well known, lung toxicity has not been reported. We describe the case of a 65-year-old man with multiple myeloma (IgG kappa) in stage IA who, on the thirty-seventh day of treatment with thalidomide, developed acute coughing, general malaise, dyspnea at rest and sudoresis. Blood pressure was 90/60 mm Hg and temperature was normal. An interstitial and alveolar pattern was visible on the right side of a chest film and arterial blood gases indicated partial respiratory insufficiency (pH 7.40, PaCO2 40 mmHg, PaO2 47 mmHg). Blood analysis showed alterations expected for multiple myeloma and microbiology was negative (sputum and blood cultures and urina…

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryUrinary systemmedicine.diseaseGastroenterologyrespiratory tract diseasesThalidomideBlood pressureInternal medicinemedicineArterial bloodSputummedicine.symptomRespiratory systemAdverse effectbusinessMultiple myelomamedicine.drugArchivos de Bronconeumología
researchProduct

Hematologic toxicity of radium-223 in elderly patients with metastatic Castration Resistant Prostate Cancer: a real-life experience

2019

Background: Treatment with radium-223 has been shown to increase survival and to delay skeletal events related to bone metastases of patients with metastatic Castration Resistant Prostate Cancer (mCRPC). This treatment has also proved to be well tolerated, and hematological toxicity, in particular anemia, represents the most represented adverse event. Materials and methods: We evaluated the hematologic toxicity of Ra-223 treatment in a real-life experience of 38 patients from two Italian cancer centers, with bone metastases from mCRPC. The main endpoint of the study was the evaluation of the efficacy and tolerability of treatment with radium-223, with greater reference to hematological toxi…

Radium-223medicine.medical_specialtyAnemiaUrology030232 urology & nephrologyNeutropenialcsh:RC870-923Ra-22303 medical and health sciencesProstate cancer0302 clinical medicineInternal medicinemedicineAdverse effectCancerToxicitybusiness.industryProstatemedicine.diseaselcsh:Diseases of the genitourinary system. UrologyDiscontinuationOlderTolerabilityDocetaxel030220 oncology & carcinogenesisOriginal Articlebusinessmedicine.drugProstate International
researchProduct

Endoscopic treatment of intraluminal ureteral suture with holmium laser

2021

Although reconstructive surgery is the most accepted treatment for ureteral injury, there are reports of cases where endourologic treatment led to correct resolution of the problem. We present the case of a female patient aged 72-year-old who was previously underwent sacralcolpopexy because of anterior vaginal compartment prolapse. The patient underwent surgery to remove the mesh, due to the pain she had had since it was placed. A mid-line laparotomy was performed removing completely the mesh. At 48 hours after intervention, the patient started feeling an intense pain in the left renal fossa that was not relieved with anti-inflammatories and morphic drugs. In the diagnostic ureteroscopy, it…

Reconstructive surgerymedicine.medical_specialtyUrologymedicine.medical_treatmentLasers Solid-StateAsymptomaticHolmiumUreterSuture (anatomy)LaparotomymedicineUreteroscopyHumansUreteroscopyAgedmedicine.diagnostic_testSuturesbusiness.industryStentDiseases of the genitourinary system. UrologySurgeryUreteral traumamedicine.anatomical_structureFemaleStentsRC870-923medicine.symptomUreterHomium laserbusinessLigationEndourologyArchivio Italiano di Urologia e Andrologia
researchProduct